HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias - Quiz - MDSpire

HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias

  • By

  • Rony Mshaik

  • John Simonet

  • Aleksandra Georgievski

  • Layla Jamal

  • Shaliha Bechoua

  • Paola Ballerini

  • Pierre-Simon Bellaye

  • Zandile Mlamla

  • Jean-Paul Pais de Barros

  • Audrey Geissler

  • Pierre-Jean Francin

  • François Girodon

  • Carmen Garrido

  • Ronan Quéré

  • March 18, 2021

  • 0 min

Share

Original Source(s)

HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias

  • by Rony Mshaik, John Simonet, Aleksandra Georgievski, Layla Jamal, Shaliha Bechoua, Paola Ballerini, Pierre-Simon Bellaye, Zandile Mlamla, Jean-Paul Pais de Barros, Audrey Geissler, Pierre-Jean Francin, François Girodon, Carmen Garrido, Ronan Quéré

  • March 18, 2021

Related Content

The 51st Annual Meeting of the European Society for Blood and Marrow Transplantation: Van Bekkum Awards

  • November 5, 2025

Dana-Farber Cancer Institute and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center recognized for exceptional outcomes in donor stem cell transplants

Dana-Farber Cancer Institute’s adult stem cell transplant program and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center’s pediatric stem cell transplant program have once again received exceptional ratings from the Center for International Blood & Marrow Transplant Research (CIBMTR), earning a +1 performance score, the highest possible designation, on their annual center-specific survival reports.

  • by

  • December 17, 2025

  • 4 min
Delays in Diagnosis of Hematological Cancers in Children: An Analysis of Symptom Recognition to Diagnosis Timeline and Contributing Factors at a Tertiary Hospital in Uganda